LeonaBio ATHA Stock
LeonaBio Price Chart
LeonaBio ATHA Financial and Trading Overview
| LeonaBio stock price | 6.75 USD |
| Previous Close | 7.19 USD |
| Open | 7.3 USD |
| Bid | 2.94 USD x 200 |
| Ask | 5.06 USD x 200 |
| Day's Range | 6.63 - 7.35 USD |
| 52 Week Range | 2.2 - 8.36 USD |
| Volume | 70.31K USD |
| Avg. Volume | 1.07M USD |
| Market Cap | 26.62M USD |
| Beta (5Y Monthly) | 2.802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4 USD |
ATHA Valuation Measures
| Enterprise Value | 1.52M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.141104 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.99381626 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.04 |
Trading Information
LeonaBio Stock Price History
| Beta (5Y Monthly) | 2.802 |
| 52-Week Change | 11.19% |
| S&P500 52-Week Change | 16.86% |
| 52 Week High | 8.36 USD |
| 52 Week Low | 2.2 USD |
| 50-Day Moving Average | 5.63 USD |
| 200-Day Moving Average | 4.12 USD |
ATHA Share Statistics
| Avg. Volume (3 month) | 1.07M USD |
| Avg. Daily Volume (10-Days) | 57.5K USD |
| Shares Outstanding | 3.94M |
| Float | 981.2K |
| Short Ratio | 0.37 |
| % Held by Insiders | 13.36% |
| % Held by Institutions | 85.51% |
| Shares Short | 7.03K |
| Short % of Float | 0.20% |
| Short % of Shares Outstanding | 0.18% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.21% |
| Return on Equity (ttm) | -89.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -38295000 USD |
| Net Income Avi to Common (ttm) | -37723000 USD |
| Diluted EPS (ttm) | -9.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 25.23M USD |
| Total Cash Per Share (mrq) | 6.4 USD |
| Total Debt (mrq) | 912K USD |
| Total Debt/Equity (mrq) | 3.41 USD |
| Current Ratio (mrq) | 9.697 |
| Book Value Per Share (mrq) | 6.792 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -52345000 USD |
| Levered Free Cash Flow (ttm) | -30363876 USD |
Profile of LeonaBio
| Country | United States |
| State | WA |
| City | Bothell |
| Address | 18706 North Creek Parkway |
| ZIP | 98011 |
| Phone | 425 620 8501 |
| Website | https://www.athira.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. Athira Pharma, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.
Q&A For LeonaBio Stock
What is a current ATHA stock price?
LeonaBio ATHA stock price today per share is 6.75 USD.
How to purchase LeonaBio stock?
You can buy ATHA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LeonaBio?
The stock symbol or ticker of LeonaBio is ATHA.
Which industry does the LeonaBio company belong to?
The LeonaBio industry is Biotechnology.
How many shares does LeonaBio have in circulation?
The max supply of LeonaBio shares is 3.94M.
What is LeonaBio Price to Earnings Ratio (PE Ratio)?
LeonaBio PE Ratio is 0.00000000 now.
What was LeonaBio earnings per share over the trailing 12 months (TTM)?
LeonaBio EPS is 0 USD over the trailing 12 months.
Which sector does the LeonaBio company belong to?
The LeonaBio sector is Healthcare.
LeonaBio ATHA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}